Neutra Corp (OTCMKTS:NTRR) Tries to Get the Bounce in Gear

Neutra Corp (OTCMKTS:NTRR) Tries to Get the Bounce in Gear

SHARE

One sub-penny that has sparked some interest in recent days is Neutra Corp (OTCMKTS:NTRR). Shares have popped up to test the stock’s 50-day simple moving average in response to news that the company just announced that it has paid two convertible notes in recent months, thereby reducing its short-term debt by $373,940 and putting the Company in a strong position as the year comes to a close.

According to the release, “the note repayments continue a string of success Neutra has enjoyed over the past 10 months, including several important completed acquisitions and one now pending. The two notes retired consisted of a $73,940 convertible note that was due Sep. 24 and a $300,000 one due Oct. 24. The notes provided financing that enabled Neutra to grow and acquire additional assets.”

Neutra Corp (OTCMKTS:NTRR) bills itself as an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market.

Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture—one where in which consumers are demanding access to products that promote health and stave off potential health dangers.

One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate.

According to company materials, “Neutra Corp. was incorporated in Nevada on January 11, 2011 to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, we plan to research and bring new technology to the nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body’s vital ability to heal and maintain itself. One of the nutraceutical sub-markets is the new thriving medical cannabis market, in which we intend to participate. We intend to entrust the manufacturing to a nutraceutical contractor to private label all of our products and to sell them under our unique brand. As the global cannabis market grows exponentially, it is constantly in need of better technologies and products to be more efficient in how it grows, what it grows and how it consumes cannabis and its related products. From lighting to dosage devices, from pesticide replacements to plant enhancers, Neutra Corp. is constantly combing the industry for the latest and greatest to test, prove and bring to market.”

Find out when $NTRR reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

As noted above, NTRR just announced that it has paid two convertible notes in recent months, thereby reducing its short-term debt by $373,940 and putting the Company in a strong position as the year comes to a close.

We’ve witnessed 70% piled on for shareholders of the company during the trailing month. In addition, the company has seen a growing influx of trading interest, with the stock’s recent average trading volume running 53% above the average volume levels in play in this stock over the longer term.

“This is a sign of tremendous forward progress for our Company,” said Neutra CEO Sydney Jim. “Retiring these notes on time shows our business strategies are working and that we are on the path to outstanding success. I thank our shareholders for their faith in the Company and our vision to become a vertically integrated provider of quality hemp-based CBD products. This has been a great year so far. We look forward to a strong finish and we will keep you updated on new developments.”

Currently trading at a market capitalization of $545K, NTRR has virtually no cash on the books, which stands against about $1.1M in total current liabilities. The company is pre-revenue at this point. We will update the story again soon as further details emerge. Sign-up for continuing coverage on shares of $NTRR stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $NTRR, either long or short, and we have not been compensated for this article.

Sign Up for our 100% FREE Oracle Dispatch Newsletter